5 December 2023 - The Government has published new terms for the Statutory Scheme for branded medicines, maintaining sales rebates ...
20 November 2023 - Pro-innovation and pro-competition agreement will introduce a new mechanism to support lower industry payment rates for more ...
27 October 2023 - Latuda is a drug to treat schizophrenia. It costs about $4,000 per month in the US. ...
12 October 2023 - Today, the Honourable Mark Holland, Minister of Health, announced a new appointment to the Patented Medicine Prices ...
9 October 2023 - Over twenty industry leaders from companies supplying the NHS with essential medicines warn that radical plans to ...
20 September 2023 - A recent report by the Patented Medicine Prices Review Board shows increased growth for private drug ...
22 August 2023 - The Patented Medicine Prices Review Board published today the 7th edition of its annual Meds Entry Watch ...
19 July 2023 - In a move that will further damage UK life sciences investment, the Government has launched a ...
4 May 2023 - Negotiations for a new voluntary scheme for branded medicines pricing to open between the government, NHS ...
27 April 2023 - Health Minister Jean-Yves Duclos says he has not exercised any undue political pressure on the independent ...
14 April 2023 - Overpaying for medicines diverts funds away from other treatments and services. ...
5 April 2023 - Germany’s pharmaceutical market is the most important one on the European continent. ...
14 March 2023 - A member of Canada’s drug pricing regulator has resigned, stating the federal government has undermined the ...
17 March 2023 - Over the past six years, the Patented Medicine Prices Review Board – Canada’s federal drug-price regulating agency ...
1 March 2023 - Review board 'will never be subjected to political interference,' Duclos said. ...